The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
暂无分享,去创建一个
H. Alper | S. Bayraktaroğlu | R. Savaş | Y. Aydinok | Selen Bayraktaroğlu | Recep Savaş | Yeşim Aydinok | Dilek Yildiz | Hatice Uluer | Hüdaver Alper | H. Uluer | D. Yildiz
[1] D. Pennell,et al. Normalized Left Ventricular Volumes and Function in Thalassemia Major Patients with Normal Myocardial Iron. , 2005 .
[2] J. M. Walker. The heart in thalassaemia. , 2002, European heart journal.
[3] V. Positano,et al. Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients , 2010, Magnetic resonance in medicine.
[4] D. Pennell. T2* Magnetic Resonance and Myocardial Iron in Thalassemia , 2005, Annals of the New York Academy of Sciences.
[5] M. Cappellini,et al. Survival and Disease Complications in Thalassemia Major , 1998, Annals of the New York Academy of Sciences.
[6] E. Gotsis,et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. , 2007, Haematologica.
[7] Marvin D Nelson,et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. , 2004, Blood.
[8] N. Olivieri. The beta-thalassemias. , 1999, The New England journal of medicine.
[9] E. Eracleous,et al. Low Serum Ferritin Levels are Misleading for Detecting Cardiac Iron Overload and Increase the Risk of Cardiomyopathy in Thalassemia Patients. The Importance of Cardiac Iron Overload Monitoring Using Magnetic Resonance Imaging T2 and T2* , 2006, Hemoglobin.
[10] Thomas D. Coates,et al. Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.
[11] D. Pennell,et al. Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload. , 2003, European heart journal.
[12] B. Akpınar,et al. Dual-echo TFE MRI for the assessment of myocardial iron overload in beta-thalassemia major patients. , 2010, Diagnostic and interventional radiology.
[13] T. S. St. Pierre,et al. Measurement and Mapping of Liver Iron Concentrations Using Magnetic Resonance Imaging , 2005, Annals of the New York Academy of Sciences.
[14] J. Wood,et al. Diagnosis and management of transfusion iron overload: The role of imaging , 2007, American journal of hematology.
[15] D. Pennell,et al. Journal of Cardiovascular Magnetic Resonance Open Access Combined Chelation Therapy in Thalassemia Major for the Treatment of Severe Myocardial Siderosis with Left Ventricular Dysfunction , 2008 .
[16] G. Link,et al. Pathophysiology of Iron Overload a , 1998, Annals of the New York Academy of Sciences.
[17] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[18] D. Farmakis,et al. Cardiac status in well‐treated patients with thalassemia major , 2004, European journal of haematology.
[19] S. Colan,et al. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. , 2008, JACC. Cardiovascular imaging.
[20] T. S. St. Pierre,et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.
[21] D. Pennell,et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance , 2004, British journal of haematology.
[22] D J Pennell,et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major , 2009, Circulation.
[23] D. Alehan,et al. The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance , 2010, The International Journal of Cardiovascular Imaging.
[24] D. Canatan,et al. Hemoglobinopathy Control Program in Turkey , 2006, Public Health Genomics.
[25] D. Pennell,et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[26] G. Brittenham,et al. Iron-chelating therapy and the treatment of thalassemia. , 1997, Blood.
[27] R. Moats,et al. Physiology and Pathophysiology of Iron Cardiomyopathy in Thalassemia , 2005, Annals of the New York Academy of Sciences.
[28] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[29] M. Tsironi,et al. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. , 2005, Chest.